Vyvanse, a medication with lisdexamfetamine, is prescribed for ADHD and binge-eating disorder. It functions by increasing dopamine levels, improving focus and reducing impulsive behaviors. As a prodrug, it necessitates metabolic conversion for activation, leading to a smoother, prolonged effect. Side effects such as insomnia and appetite changes may occur. Vyvanse's prodrug nature reduces the risk of misuse. Responsible use under medical supervision is vital to prevent dependency. Regular communication with healthcare providers ensures proper dosage adjustments and monitoring for optimal treatment outcomes in managing ADHD or binge-eating disorder.